← Back

AMGN · Nasdaq · Biological Products, (No Diagnostic Substances)

Amgen Inc

Overview

Amgen Inc is listed on Nasdaq and classified as Biological Products, (No Diagnostic Substances). We have no business description beyond that classification; its SEC filings describe the business.

What we have on this company
InformationStatusAs of
Detailed research reportNo report
Rule-based screensScored, on no current shortlist2026-10-31
ValuationModel 336.03 (-28% vs price)2026-10-31
Chart-pattern readNo read
Paper portfolioNever held

Scores

Deterministic rule outputs, snapshot 2026-10-31 · price 466.01 on 2026-10-30. Not recommendations.

MethodScoreInputs as ofFlags
Graham Defensive462025-12-31 stale input
Magic Formula492025-12-31 stale input
Momentum832026-10-30
Insider02026-10-30
Buffett Quality622025-12-31 stale input
Lynch GARP212025-12-31 stale input
Graham Enterprising462025-12-31 stale input
Piotroski F-Score89

Every input with its filing: full score sheet · research packet (JSON) · Markdown · SEC filings.

Valuation

Model estimate from SEC filings · calculated 2026-10-31 from the 2026-10-30 close · filings through 2026-08-05

336.03 -28% vs price

Range 83.20 to 361.55, 3 of 3 methods agree. A labelled model estimate, not a price target. Method.